46 related articles for article (PubMed ID: 32106804)
1. The potential role of formononetin in cancer treatment: An updated review.
Aliya S; Alhammadi M; Park U; Tiwari JN; Lee JH; Han YK; Huh YS
Biomed Pharmacother; 2023 Dec; 168():115811. PubMed ID: 37922652
[TBL] [Abstract][Full Text] [Related]
2. Ononin: A comprehensive review of anticancer potential of natural isoflavone glycoside.
Sharma U; Sharma B; Mishra A; Sahu A; Mathkor DM; Haque S; Raina D; Ramniwas S; Gupta M; Tuli HS
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23735. PubMed ID: 38773908
[TBL] [Abstract][Full Text] [Related]
3. Monoterpenoids: An upcoming class of therapeutic agents for modulating cancer metastasis.
Mathur A; Meena A; Luqman S
Phytother Res; 2024 Feb; 38(2):939-969. PubMed ID: 38102850
[TBL] [Abstract][Full Text] [Related]
4. The beneficial health effects of puerarin in the treatment of cardiovascular diseases: from mechanisms to therapeutics.
Wan Q; Lu Q; Luo S; Guan C; Zhang H
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38709267
[TBL] [Abstract][Full Text] [Related]
5. Natural Anticancer Molecules and Their Therapeutic Potential.
Zhang J; Leung EL
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003270
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic analyses reveal that Pueraria montana var. lobata (Willd.) is effective in inhibiting ovarian cancer progression.
Lin C; Su T; Ye YJ
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38809293
[TBL] [Abstract][Full Text] [Related]
7. The effect of soil environmental factors on the yield and quality of Pueraria lobata.
Li F; Li Y; Huang J; Li J; Xiao D; Li Y; He L; Wang AQ
Sci Rep; 2023 Oct; 13(1):18717. PubMed ID: 37907647
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of puerarin in rats with focal cerebral ischemia through modulation of the SIRT1/HIF-1α/VEGF signaling pathway and its effect on synaptic plasticity.
Liu X; Sui X; Zhang Y; Yue R; Yin S
Heliyon; 2023 May; 9(5):e15872. PubMed ID: 37223716
[TBL] [Abstract][Full Text] [Related]
9. Comparative Transcriptome Analysis of
Xi H; Zhu Y; Sun W; Tang N; Xu Z; Shang X; Zhang Y; Yan H; Li C
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671554
[No Abstract] [Full Text] [Related]
10. Protective effects and mechanism of puerarin targeting PI3K/Akt signal pathway on neurological diseases.
Wang Q; Shen ZN; Zhang SJ; Sun Y; Zheng FJ; Li YH
Front Pharmacol; 2022; 13():1022053. PubMed ID: 36353499
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and
Zha D; Li Y; Luo Y; Liu Y; Lin Z; Lin C; Chen S; Wu J; Yu L; Chen S; Zhang P; Wu W; Zhang C
RSC Med Chem; 2022 Sep; 13(9):1082-1099. PubMed ID: 36324491
[TBL] [Abstract][Full Text] [Related]
12. Anticancer Effect of Puerarin on Ovarian Cancer Progression Contributes to the Tumor Suppressor Gene Expression and Gut Microbiota Modulation.
Ye Y; Gao Y; Fang Y; Xu L; He F
J Immunol Res; 2022; 2022():4472509. PubMed ID: 35935578
[TBL] [Abstract][Full Text] [Related]
13. An Overview on the Conservative Management of Endometriosis from a Naturopathic Perspective: Phytochemicals and Medicinal Plants.
Balan A; Moga MA; Dima L; Dinu CG; Martinescu CC; Panait DE; Irimie CA; Anastasiu CV
Plants (Basel); 2021 Mar; 10(3):. PubMed ID: 33804660
[TBL] [Abstract][Full Text] [Related]
14. A Critical Review on Anticancer Mechanisms of Natural Flavonoid Puerarin.
Murahari M; Singh V; Chaubey P; Suvarna V
Anticancer Agents Med Chem; 2020; 20(6):678-686. PubMed ID: 32106804
[TBL] [Abstract][Full Text] [Related]
15. Puerarin induced in mantle cell lymphoma apoptosis and its possible mechanisms involving multi-signaling pathway.
Gan M; Yin X
Cell Biochem Biophys; 2015 Jan; 71(1):367-73. PubMed ID: 25173778
[TBL] [Abstract][Full Text] [Related]
16. Puerarin attenuates glucocorticoid-induced apoptosis of hFOB1.19 cells through the JNK- and Akt-mediated mitochondrial apoptotic pathways.
Yu D; Mu S; Zhao D; Wang G; Chen Z; Ren H; Fu Q
Int J Mol Med; 2015 Aug; 36(2):345-54. PubMed ID: 26101183
[TBL] [Abstract][Full Text] [Related]
17. The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism.
Zhu H; Xiao Y; Guo H; Guo Y; Huang Y; Shan Y; Bai Y; Lin X; Lu H
Aging (Albany NY); 2021 Dec; 13(23):25089-25105. PubMed ID: 34863080
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment.
Ahmad A; Biersack B; Li Y; Kong D; Bao B; Schobert R; Padhye SB; Sarkar FH
Anticancer Agents Med Chem; 2013 Sep; 13(7):1014-24. PubMed ID: 23272911
[TBL] [Abstract][Full Text] [Related]
19. PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives.
Asati V; Mahapatra DK; Bharti SK
Eur J Med Chem; 2016 Feb; 109():314-41. PubMed ID: 26807863
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
